SCHEMBL2332774

SCHEMBL2332774

CCO[C@H](Cc1ccc(OCCc2ccc(CC)cn2)cc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 18/20 0.61
PPARG P37231 15/20 0.61
PPARD Q03181 7/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2332479 1.00 PPARA (0.61) PPARAPPARGPPARD
SCHEMBL2361274 1.00 PPARA (0.61) PPARAPPARGPPARD
SCHEMBL6813813 0.86 PPARA (0.76) PPARAPPARGPPARD
SCHEMBL5803154 0.84 PPARG (0.52) PPARAPPARGPPARD
SCHEMBL3313236 0.84 PPARG (0.58) PPARAPPARGPPARD
SCHEMBL4874828 0.84 PPARG (0.58) PPARAPPARG
SCHEMBL6529677 0.84 PPARA (0.53) PPARAPPARGPPARD
Hydrochloric Acid SCHEMBL5738405 0.83 PPARG (0.57) PPARAPPARG
SCHEMBL27674855 0.83 PPARA (0.81) PPARAPPARGPPARD
SCHEMBL13475126 0.82 PPARG (0.69) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012177956-A1 PPAR-SPARING COMPOUNDS FOR USE IN THE TREATMENT OF DIABETES AND OTHER METABOLIC DISEASES METABOLIC SOLUTIONS DEVELOPMENT COMAPNY, LLC (US) 2012-12-27 WO disclosed
WO-2011098801-A1 INFLAMMATORY DISEASE TREATMENT PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED (GB) 2011-08-18 WO disclosed
WO-2011098801-A1 INFLAMMATORY DISEASE TREATMENT PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED (GB) 2011-08-18 WO disclosed